Endocrine/metabolic Boehringer Ingelheim Pharma GmbH & Co. KG …

Boehringer Ingelheim and Simcere have announced a … immunology and respiratory diseases at Boehringer Ingelheim, said: “In IBD, too many … for IBD treatment. “Partnering with Boehringer Ingelheim, with its long term commitment …

… in the 60-second ad.  Boehringer Ingelheim shoots flares up for high … — urine albumin-to-creatinine ratio — Boehringer Ingelheim tapped Octavia Spencer and Sofía … like heart attacks or strokes. Boehringer Ingelheim worked with longtime agency partner …

… active allies in the fight.” Boehringer Ingelheim Boehringer Ingelheim’s ad stars Octavia Spencer …

… on January 20, 2026, that Boehringer Ingelheim has selected them to provide … for rheumatology and pulmonology at Boehringer Ingelheim Pharmaceuticals, emphasized the unmet need …

… dozen drug companies including Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly … ” drug pricing deals with Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead …

… president, Human Pharma Business Law Boehringer Ingelheim Vanessa Thomas, vice president, associate …

… , Alkeus, Amgen, Apellis, Astellas, Aviceda, Boehringer Ingelheim, Clearside, EyeBio, Eyedaptic, EyePoint, Genentech …

… SGLT2 inhibitor, including empagliflozin (Jardiance, Boehringer Ingelheim) or dapagliflozin (Farxiga, AstraZeneca) or …

Deals: Boehringer Ingelheim agreed to a pact with …